Biopharmaceutical Company Silo Pharma Launches Cryptocurrency Fund Management Strategy
ChainCatcher reports that biopharmaceutical company Silo Pharma (NASDAQ: SILO) has announced the launch of a cryptocurrency fund management strategy and appointed crypto infrastructure expert Corwin Yu as the first member of its Cryptocurrency Advisory Board. The strategy will focus on major digital assets such as Bitcoin, Ethereum, and SOL.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Data: 5.1665 million AVNT transferred to a certain exchange, worth approximately $2.35 million
Data: Bitcoin hash rate drops to a five-year low
US-listed company Onfolio Holdings secures up to $300 million in funding to build a digital asset treasury
Trending news
MoreCrypto prices
More
